|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/50 | |
| A61P 43/00 |
| (11) | Number of the document | 3193942 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15756512.8 |
| Date of filing the European patent application | 2015-08-11 | |
| (97) | Date of publication of the European application | 2017-07-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/044718 |
| Date | 2015-08-11 |
| (87) | Number | WO 2016/025523 |
| Date | 2016-02-18 |
| (30) | Number | Date | Country code |
| 201462036084 P | 2014-08-11 | US |
| (72) |
CONCINO, Michael F., US
STRACK-LOGUE, Bettina, US
MEIYAPPAN, Muthuraman, US
NORTON, Angela W., US
ZHANG, Bohong, US
ISKENDERIAN, Andrea, US
FENG, Jianwen, US
HOLMES, Kevin, US
PAN, Jing, US
|
| (73) |
Shire Human Genetic Therapies, Inc.,
300 Shire Way, Lexington, MA 02421,
US
|
| (54) | LYSOSOMAL TARGETING AND USES THEREOF |
| LYSOSOMAL TARGETING AND USES THEREOF |